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Abstract From our previous studies, several protein tyrosine 
phosphatases (PTPase) are implicated in the early events leading 
to in vitro differentiation of both mouse erythroleukemia (MEL) 
and embryonal carcinoma (F9) cells. Among the PTPases, recent 
experiments uggest hat a new PTPase (RIP) plays a critical 
role in differentiation processes, particularly at their early stages. 
We isolated eDNA clones for RIP from a RNA preparation 
isolated from differentiating MEL cells, and determined the total 
7932 hp base sequence for RIP cDNA. The cDNA codes for a 
putative 269.8 kDa (2450 amino acids) protein with a PTPase 
catalytic domain. We have demonstrated that the transcripts 
exist in multiple forms, and among mouse tissues they were found 
predominantly in kidney and, to a lesser extent, in lung, heart, 
brain and testis. The RIP gene was mapped between D5MitgO 
and DSMit25 on mouse chromosome 5. 
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usually present at a very low level in the cells, are induced at 
an early stage after addition of inducers. Furthermore, the 
induction was not observed in MEL and F9 mutant cells defec- 
tive in differentiation [4,5]. In this paper, we report cloning of 
eDNA for RIP, its total base sequence, characterization and 
tissue distribution of the transcripts, and chromosomal location 
of the gene. 
2. Materials and methods 
2.1. Cells and cell culture 
MEL (Friend) cells (745A) and differentiation-resistant MEL cells 
(Dif-1 and Dif-2) [41 were cultured at 37°C in a COz (5%) incubator in 
minimal essential medium supplemented with 12% (v/v) fetal calf 
serum. 
2.2. Northern blot analys& 
Northern blot analysis was carried out as described previously [4]. 
A mouse multiple tissue Northern blot membrane (MTN, Clontech) 
was used for the analysis of the tissue distribution of the transcripts. 
I. Introduction 
Previously, we presented evidence that the dephosphoryla- 
tion of phosphorylated tyrosine moieties of specific cellular 
proteins plays an important role in triggering differentiation of 
mouse erythroleukemia (MEL) as well as embryonal carcinoma 
(F9) cells [1-5]. Besides extensive dephosphorylation of tyro- 
sine-phophorylated cellular proteins at a very early stage of 
differentiation [3], other experimental evidence for involvement 
of tyrosine dephosphorylation i cellular differentiation in- 
cludes; induction of MEL and F9 cell differentiation by protein 
tyrosine kinase inhibitors [1], inhibition of differentiation by a 
specific inhibitor (Na3VO4) of PTPases [3], and lack of tyrosine 
dephosphorylation in differentiation-defective mutant cells [3]. 
Furthermore, we found that the level of transcripts for several 
specific PTPases sharply increases at an early stage of differen- 
tiation of MEL and F9 cells [4,5]. Interestingly, among four 
PTPase transcripts which displayed an increase, three of them 
were commonly induced during both MEL  and F9 cell differen- 
tiation, despite the fact that these cells exhibit entirely different 
patterns of differentiation. 
Among these PTPases, the induction of RIP, an apparently 
new PTPase, was most striking. RIP transcripts, which are 
*Corresponding author. Fax: (81) (3) 3818-9437. 
2.3. Cloning of RIP cDNA clones 
RNA was isolated from MEL cells which had been incubated with 
Me2SO for 24 h and poly(A) ÷ RNA was then obtained by using Oligo- 
tex beads (Roche, Japan) as described before [4]. A cDNA library was 
constructed from the poly(A) ÷ RNA using a ZAP cDNA synthesis kit 
(Stratagene). In essence, the poly(A) + RNA (7/tg) was annealed to an 
oligo dT primer (5'-GAGAGAGAGAGAGAGAGAGAACTCGAG- 
TTTTTTTTTTTTTTTTT-3') and the first and second cDNA strands 
were synthesized by MMLV reverse transcriptase (Superscript II; 
BRL), and by E. coli RNase H and DNA polymerase I. The double- 
stranded cDNA was blunted by T4 DNA polymerase, ligated to EcoRI 
adapters and phosphorylated. After XhoI digestion, the cDNA was 
purified by a Sephacryl S-400 column, cloned into Uni-Zap XR 1I 
vector and packaged using a Gigapack II packaging extract (Strat- 
agene). 
Phage clones were transferred onto nylon membranes (Hybond-N+; 
Amersham) and hybridized with a 367 bp RIP (MTC) probe [6] which 
had been labeled with [32p]dCTP (111TBq/mmol; ICN) using the ran- 
domly primed DNA labeling kit (Boeringer Mannheim) as described 
previously [4]. Inserts of several dozens of clones which gave positive 
signals by the probe were subjected to structural analysis and a clone 
(45-29) with the largest insert (-6850 bp) was selected. After partial 
sequencing of the insert, 5'-RACE was performed to obtain sequence 
information for the full-length RIP cDNA. 
5' RACE was performed by using the 5'-Amplifinder RACE kit 
(Clontech). Briefly, poly(A) + RNA (2/lg) was annealed to primer P3 
(5'-CACTGCTGGATTCAAACCTC-3') (nt. 1315-1296) and the first 
cDNA strand was synthesized by AMV reverse transcriptase. After 
alkaline RNA hydrolysis, eDNA was purified by Genobind suspension 
(Clontech) and ligated with an anchor (5'-GGAGACTTCCAAGGT- 
CTTAGCTATCACTTAAGCAC-3') by T4 RNA ligase. The cDNA 
was then subjected to the first PCR. The primer sets used were an 
anchor primer (5"-CTGGTTCGGCCCACCTCTGAAGGTTCCAG- 
0014-5793/95/$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
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AATCGATAG-Y) and primer P2 (5'-CTCGCTCGCCCACTCGA- 
GGAAATAACAGATGGGCTTTCACTG-3') (nt. 1250-1227). The 
PCR conditions were: denaturation at 94°C (2 min), followed by 30 
cycles at 94°C (1 min), 55C ° (2 rain) and 72C ° (4 min), and the final 
incubation at 72°C for 7 rain. Amplified DNA was electrophoresed on 
an agarose (1.5%) gel, extracted from the gel, purified and ligated to 
pGEM T vector (Promega). A clone with DNA extended to the furthest 
5' position (nt. 60) was selected and the DNA sequenced. A second PCR 
was then performed on the same first cDNA strand as a template using 
the anchor primer and primer P6 (5'-ATCCGTAAAGGACA- 
CACTGC-Y) (nt. 204-185) as described above to clone 5' DNA se- 
quences proximal to the first PCR products. Significant portions of the 
amplified DNA consisted of~250 bp (or slightly less) sequences and they 
were cloned into pGEM T vector as for the first PCR products and their 
sequences were determined. We performed another ound of 5"-RACE 
to find 5' sequences further extended from the second PCR products, 
but no extended products were detected (data not shown). 
2.4. DNA sequencing 
The DNA sequences were determined for both strands by the dide- 
oxy chain-termination method [7] with denatured ouble-stranded 
DNA as a template after constructing nested eletions. Sequencing was 
performed by using Sequenase quencing kit (United States Biochem- 
icals) and Taq Dye primer cycle sequencing kit (Applied Biosystems). 
2.5. RT-PCR 
RT-PCR was performed by using SuperScript pre-amplification sys- 
tem (Gibco BRL). cDNA was synthesized from total RNA (2 rag) using 
random hexamers, treated with RNase H and subjected to PCR. 
Primers used were P1 (5'-GTAGCAGTGAACAAAAACCTGACCG- 
GAG-3') (nt. 560 587), P2 (see above), P7 (5'-ACCCAAACTGCAT- 
AACACCT-3') (nt. 2217-2238) and P8 (5'-CCTAAGCCGTGTCTT- 
GGATC-Y) (nt. 3284-3265). PCR conditions were: denaturation at 
94°C (3 min), followed by 35 cycles at 94°C (0.5 rain), 55°C (1 rain), 
72°C (1.5 rain) and 72°C (4 rain). 
2.6. Interspecific backcross mapping for the chromosomal positioning of 
the RIP gene 
The 6.5-kb SpeI-KpnI fragment was hybridized to TaqI-digested 
DNA from European Collaborative Interspecific Backcross (EUCIB). 
F1 females from the cross of two parental mice, C57BL/6 and Mus 
spretuss, were backcrossed to C57BL/6 or Mus spretus males. DNA 
from each backcross progeny mouse was scored for 3-4 microsatellite 
Fig. 2 (A). For caption, see p. 236. 
-._) 
markers per chromosome, completing an anchor map of 70 loci across 
the mouse genome. A total of 36 mice were used to map the RIP gene. 
Microsatellite marker primer sets (Map Pairs) were purchased from 
Research Genetics (Huntsville, AL) and used as described [8]. Both 
C57BL/6 and Mus spretus pecific RFLP and sequence variations were 
followed in backcross mice. The informative RFLP was a 8.6-kb frag- 
ment of Mus spretus and 7.l-and 6.4-kb fragments of C57BL/6. Data 
were analyzed in the EUCIB database, Mbx. 
3. Results and discussion 
We have reported recently that several specific PTPase tran- 
scripts are induced at an early stage of in vitro differentiation 
of MEL  as well as F9 cells [4,5]. The PTPase transcripts include 
those for RIP, PTPfl2, PTPE, and PTP/.t. Among the PTPases, 
we concentrated our efforts on characterization of RIP, an 
apparently novel PTPase, because it exhibited the most drastic 
increase in transcript levels at an early stage of MEL as well 
as F9 cell differentiation while the transcripts were not detected 
(or barely detected) in mutant MEL and F9 cells defective in 
differentiation. In Fig, 1 we show the pattern of induction of 
RIP transcripts during erythroid ifferentiation of mouse MEL 
(745A) cells and their two mutant (Dif-1 and Dif-2) cells. 
Employing the previously isolated RIP (originally termed 
MTC) cDNA fragment [6] as a probe, we isolated cDNA clones 
for a full-length RIP gene product from a poly(A) + RNA prep- 
aration isolated from differentiating MEL  cells. We subse- 
quently determined the total base sequence of RIP cDNA (to 
be submitted to GenBank/EMBL Data Bank). The cDNA con- 
sists of 7932 bp, which is consistent with the molecular size of 
the RIP transcripts (~ 8 kb) detected by Northern hybridization 
[4]. In the sequence, the initiation codon is present at the 41th 
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Fig. 1. Induction of RIP transcripts during MEL cell differentiation. Exponentially grown MEL cells were exposed to Me2SO when the cell density 
reached 2-3 x 105 cells/ml. Aliquots (200 ml) were withdrawn at the time (hours) indicated and, after washing with cold PBS (2 times), the cells (~ 5 x 107 
cells) were lysed and total RNA was prepared as described previously [4]. Poly(A) ÷ RNA (2 gig) was electrophoresed on a formaldehyde-agarose 
(1%) gel, blotted onto a Hybond-N ÷ membrane and hybridized with a 367 bp RIP (MTC) cDNA [6] and GAPDH (glyceraldehyde phosphodehydoge- 
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Fig. 2. The total base sequence of RIP cDNA and deduced amino acid sequence, and alignment of RIP with conserved omains in related proteins. 
(A) The total base sequence and predicted amino acid sequence in one letter code of RIP. The open box is the segment homologous to the N-terminal 
of protein 4.1 super family• The shaded box is the segment homologous to the catalytic domain of PTPases, in which the active site for PTPase activity 
is underlined by a bold line. GLGF repeats are underlined. (B) Proposed alignment of the PTPase catalytic domain of RIP with that of PTP-MEG 
(11), TC-PTP [12], PTP-ALPHA [13] and CD45 [14]. Conserved residues in these proteins are shaded. (C) Proposed alignment of the putative 
membrane binding domain of RIP and that of protein 4.1 [15] and Ezrin [16]. Conserved residues in these proteins are shaded• (D) Proposed alignment 
of GLGF repeats of RIP and that of psd-95 [17], dig [18] and NOS [19]. Conserved residues in these proteins are shaded. Throughout A-D, the residue 
numbers of the initial amino acid of each PTPase are indicated at the left hand. 
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Fig. 3. Comparison of amino acid sequences of RIP and human PTP- 
BAS. Diagonal plots were made using the HarrPlot Program [10]. The 
axes are labeled with amino acid numbers where the amino acid at the 
N-terminus (methionine) is 1. 
open reading frame (7350 bp). In Fig. 2A, we show the total 
base sequence of RIP cDNA and the deduced amino acid 
sequence with 2450 amino acid residues (MW of 269.8 kDa). 
An homology search (Swiss Plot Data Base) of the amino acid 
sequence revealed a typical PTPase catalytic domain at the 
position close to the C-terminus (amino acid 2198-2450), which 
is conserved among almost all PTPases [9,10] (Fig. 2B). No 
transmembrane domains were detected in the sequence, sug- 
gesting that RIP is a cytoplasmic PTPase. However, the search 
also revealed the presence of a domain at amino acid sequence 
561-576 which is believed to be essential for the association of 
protein 4.1 and its super family (ERM family) members with 
transmembrane proteins [20] (Fig. 2C). This may indicate that 
RIP also associates with transmembrane protein(s) through 
this domain. The possible biological significance of the domain 
in RIP in the cell differentiation cascade will be discussed later. 
Another characteristic of RIP is the presence of a GLGF re- 
peat, the function of which is still unknown (Fig. 2D). 
We found that the base sequence of RIP has homology with 
the recently reported human PTPase (PTP-BAS, hPTP1E, 
PTPL1) cDNA [22-24] the biological function of which is yet 
to be understood. The homology of the amino acid sequence 
between RIP and human PTP-BAS (2485 amino acids) is 
79.0%, and the comparison of the sequence is shown in Fig. 3. 
In addition to the full-length cDNA clone we isolated several 
RIP cDNA clones the sequences of which were deleted at two 
specific places (sites A and B), as shown in Fig. 4A. To confirm 
the presence of mRNA species to these cDNA in the cells, we 
performed RT-PCR with the total RNA isolated from MEL 
cells. As shown in Fig. 4B, RT-PCR at site A gave two DNA 
bands of approximately 700 and 150 bp, respectively, which are 
explained by the presence of a RIP mRNA species pliced (544 
bp) at site A. Similarly, at site B we also detected two RT-PCR 
products which were expected from the sequence analysis (1028 
bp and 463 bp, respectively) (Fig. 4C). RT-PCR covering both 
of the A and B sites gave at least three bands of approximate 
molecular sizes of 2700, 2200 and 1600 bp, which should corre- 
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Fig. 4. Structures ofRIP cDNA variants and analysis of RT-PCR products. (A) A diagrammatic representation of structures ofRIP cDNA variants 
and the sites for PCR primers used for RT-PCR. The positions of site A and B on the full-length RIP cDNA (bold line) are shown along with the 
sites and directions of PCR primers used for RT-PCR (arrows). The nucleotide (nt) numbers are expressed asthe number of nucleotides from the 
first base of the initiation codon (nt 1). (B-D) RT-PCR analysis of RIP transcripts inMEL cells. Total RNA (2/tg) from Me2SO-treated (24 h) cells 
were subjected toRT-PCR as described insection 2. The amplified DNA was electrophoresed on an agarose gel (A, 2%; B, 1%; and C, 0.8%) and 
visualized by ethidium bromide staining. (B) PCR with primers P1 and P2. (C) PCR with primers P7 and P8. (D) PCR with primers P1 and P8. Because 
of the proximity of the molecular size, the bands corresponding to 2182 and 2159 bp (see text) can not be distinguished from each other and seen 
as a single band (the middle band) in the picture. Throughout B-D: lane 1, control (PCR without reverse transcription); lane 2, RT-PCR products; 
and lane M, DNA size markers (1 kb DNA ladder, BRL). Arrows indicate amplified DNA bands. 
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2159 bp and 1616 bp PCR products (Fig. 4D). These RT-PCR 
experiments indicate that mouse RIP transcripts exist in multi- 
ple forms. Interestingly, preliminary experiments indicated that 
the relative amount of each transcript was altered uring MEL 
cell differentiation when the total RIP transcript level was 
sharply increased, as shown in Fig. 1 (data not shown). 
We conducted Northern hybridization experiments o exam- 
ine the distribution of the RIP transcripts among various 
mouse tissues. As shown in Fig. 5, the RIP transcripts were 
predominantly found in kidney and, to a lesser extent, in lung, 
heart, brain and testis. The transcripts were also present in 
RNA in the fetuses at day 9, 10, 11 and 12 postcortum (data 
not shown). 
We attempted to determine the chromosomal location of the 
mouse RIP gene by analyzing 36 interspecific backcross DNA 
between two mouse species C57BL/6 and Mus spertus. Our 
initial analysis indicated that the RIP gene maps between 
D5Nds2 and D5Nds6 on chromosome 5.To locate the RIP gene 
more precisely on the chromosome, we selected 10 recombi- 
nants between D5Nds2 and D5Nds6, which were further typed 
for D5Mit30, D5Mit25, D5Mit240, D5Mit175 and D5Mit90 
loci. The genetic order of the loci and distances (+ one standard 
error), determined by the haplotype analysis, are as follows: 
Cen ...... D5Nds2-8.3 + 4.6cM-D5Mit90-2.8 + 2.7cM-RIP/D5Mit- 
175/D5Mit240-5.7 + 3.9cM-D5Mi t25-5.7 + 3.9cM-D5Mit30- 
2.9 + 2.8cM-D5Nds6. Thus, the RIP gene is located on mouse 
chromosome 5 between D5Mit90 and D5Mit25, as diagram- 
matically presented in Fig. 6. Finer mapping of the RIP gene 
is now in progress to obtain information regarding a possible 
linkage between RIP and any human genetic disorders. 
In this letter, we have reported the total base sequence of RIP 
eDNA and basic characteristics of the gene product. The puta- 
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Fig. 5. Tissue distribution ofRIP transcripts. A membrane immobilized 
with 2/lg of poly(A) ÷ RNA from various mouse tissues (MTN; Clone- 
tech) was hybridized with a 367 bp 32p-labeled RIP (MTC) probe [6] 
and autoradiographed as escribed previously [4]. Positions of RNA 












Fig. 6, Chromosomal location of RIP gene. Genetic distances are given 
in centimorgans (cM) and are shown for each pair of loci on the left 
of the chromosome map. 
catalytic domain close to the C-terminus. The protein does not 
have transmembrane domain(s), suggesting that RIP is in- 
volved in cellular differentiation through protein tyrosine 
dephosphorylation in the cytoplasm. As described above, RIP 
has another domain which is likely to be essential for the asso- 
ciation of cytoplasmic proteins with transmembrane proteins. 
Although the role played by the domain in RIP in the cellular 
differentiation cascade must await further investigation, it is 
attractive to speculate that transmembrane signals generated by 
differentiation i ducers uch as Me2SO (MEL cells) and reti- 
noic acid (F9 cells) are transmitted toRIP through this domain. 
As a natural extention of the results presented here and previ- 
ously, we are currently investigating whether differentiation of
MEL and F9 cells can be triggered (without differentiation 
inducers) when transfected RIP cDNA with an appropriate 
promoter is inducibly expressed. It might be interesting to note 
that the previously reported proteinaceous differentiation i - 
ducing factor (DIF-II), which induces MEL cell differentiation 
upon introduction into the cells, is of cytoplasmic origin and 
has characteristics of a PTPase with MW of slightly over 250 
kDa, [2,25]. 
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